BR9907195A - " formulações de tiagabina de liberação prolongada com efeitos colaterais reduzidos " - Google Patents
" formulações de tiagabina de liberação prolongada com efeitos colaterais reduzidos "Info
- Publication number
- BR9907195A BR9907195A BR9907195-9A BR9907195A BR9907195A BR 9907195 A BR9907195 A BR 9907195A BR 9907195 A BR9907195 A BR 9907195A BR 9907195 A BR9907195 A BR 9907195A
- Authority
- BR
- Brazil
- Prior art keywords
- prolonged
- side effects
- reduced side
- formulations
- release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
"FORMULAçõES DE TIAGABINA DE LIBERAçãO PROLONGADA COM EFEITOS COLATERAIS REDUZIDOS" Formulações de tiagabina de liberação prolongada que demonstram poucos efeitos colaterais quando administradas a um paciente.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7213098P | 1998-01-22 | 1998-01-22 | |
US23554099A | 1999-01-22 | 1999-01-22 | |
PCT/US1999/001242 WO1999037302A1 (en) | 1998-01-22 | 1999-01-22 | Extended release tiagabine formulations with reduced side-effects |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9907195A true BR9907195A (pt) | 2000-10-10 |
Family
ID=26753030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9907195-9A BR9907195A (pt) | 1998-01-22 | 1999-01-22 | " formulações de tiagabina de liberação prolongada com efeitos colaterais reduzidos " |
Country Status (2)
Country | Link |
---|---|
US (1) | US20030206952A1 (pt) |
BR (1) | BR9907195A (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030228368A1 (en) * | 2001-09-28 | 2003-12-11 | David Wynn | Edible solid composition and dosage form |
WO2005060937A1 (en) * | 2003-12-23 | 2005-07-07 | Chr. Hansen A/S | Compressed tablets comprising viable probiotic microorganisms |
DK1968523T3 (da) * | 2005-12-23 | 2012-05-29 | Gea Process Engineering As | Direkte tabletting |
US20080081069A1 (en) * | 2006-09-28 | 2008-04-03 | Lupin Limited | Novel controlled release formulations of divalproex sodium |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5009897A (en) * | 1988-06-24 | 1991-04-23 | Abbott Laboratories | Pharmaceutical granules and tablets made therefrom |
US5126145A (en) * | 1989-04-13 | 1992-06-30 | Upsher Smith Laboratories Inc | Controlled release tablet containing water soluble medicament |
US5273758A (en) * | 1991-03-18 | 1993-12-28 | Sandoz Ltd. | Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms |
WO1995005808A1 (en) * | 1993-08-24 | 1995-03-02 | Abbott Laboratories | Oil-based tableting method |
US5430021A (en) * | 1994-03-18 | 1995-07-04 | Pharmavene, Inc. | Hydrophobic drug delivery systems |
US5783212A (en) * | 1996-02-02 | 1998-07-21 | Temple University--of the Commonwealth System of Higher Education | Controlled release drug delivery system |
US5843477A (en) * | 1997-09-30 | 1998-12-01 | Bayer Corporation | Lubricants for use in tabletting |
-
1999
- 1999-01-22 BR BR9907195-9A patent/BR9907195A/pt not_active Application Discontinuation
-
2003
- 2003-04-23 US US10/421,043 patent/US20030206952A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030206952A1 (en) | 2003-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0015188A (pt) | Composições farmacêuticas | |
DE69819205D1 (de) | Orale pharmazeutische dosierungsform beruhend auf stossweiser freisetzung | |
ATE312602T1 (de) | Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung | |
NO994621D0 (no) | Ernaeringsformuleringer inneholdende oligosakkarider | |
DE60028710D1 (de) | Orale Dosiszusammensetzung mit verlängerter Freigabe | |
TR199600498A2 (tr) | S(+)-ibuprofen'in oral formülasyonlari. | |
BR0107869A (pt) | Composições farmacêuticas eletrogiradas | |
BR9712491A (pt) | Composições cosméticas | |
ES2177482T1 (es) | Preparacion mejorada de tebaina y oripavina. | |
DE69532415D1 (de) | Schmelzextrudierte oral verabreichbare opioidformulierungen | |
RS49609B (sr) | Stabilizovani antihistaminski sirup | |
ATE168560T1 (de) | Topische mittel zur transdermalen verabreichung von prodrugderivaten des morphins | |
DE59712959D1 (de) | Orale pharmazeutische zubereitung enthaltend ibandronat | |
BR0012429A (pt) | Fórmulações para il-11 | |
BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
BR0114059A (pt) | Derivados de resorcinol | |
ATE260650T1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
DK0998287T3 (da) | Anvendelse af levobupivacain | |
NZ511085A (en) | Oral pharmaceutical compositions containing buprenorphin | |
NO20011217D0 (no) | Doseringsform omfattende væskeformulering | |
AR021934A1 (es) | Composicion de administracion oral con liberacion controlada de al menos un analgesico | |
DK0629400T3 (da) | Idebenon-holdige præparater til behandling af Alzheimer's syge | |
BR9907195A (pt) | " formulações de tiagabina de liberação prolongada com efeitos colaterais reduzidos " | |
AP9801350A0 (en) | Parasitical formulations. | |
BG104692A (en) | Extended release tiagabine formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL: A61K 31/455, A61K 9/26, A61K 9/16, A61K 9/52 Ipc: A61K 31/445 (2007.10), A61K 9/22 (2007.10), A61K 9 |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI. |